Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI106533

Effects of thyroid disease on glucose oxidative metabolism in man. A compartmental model analysis

David M. Shames, Mones Berman, and Stanton Segal

1Mathematical Research Branch, and Clinical Endocrinology Branch, National Institute of Arthritis and Metabolic Diseases, Bethesda, Maryland 20014

Find articles by Shames, D. in: JCI | PubMed | Google Scholar

1Mathematical Research Branch, and Clinical Endocrinology Branch, National Institute of Arthritis and Metabolic Diseases, Bethesda, Maryland 20014

Find articles by Berman, M. in: JCI | PubMed | Google Scholar

1Mathematical Research Branch, and Clinical Endocrinology Branch, National Institute of Arthritis and Metabolic Diseases, Bethesda, Maryland 20014

Find articles by Segal, S. in: JCI | PubMed | Google Scholar

Published March 1, 1971 - More info

Published in Volume 50, Issue 3 on March 1, 1971
J Clin Invest. 1971;50(3):627–641. https://doi.org/10.1172/JCI106533.
© 1971 The American Society for Clinical Investigation
Published March 1, 1971 - Version history
View PDF
Abstract

Glucose oxidation to CO2 in man at the fasted, steady state has been investigated in normal, hypothyroid, patients by monitoring the specific activity of plasma glucose and expired CO2 after intravenous injection of glucose-1-14C, glucose-6-14C, and sodium bicarbonate-24C in tracer amounts. Making certain stoichiometric assumptions about the oxidation of the C-1 and C-6 carbons of glucose to CO2, the data are incorporated into a multicompartmental model describing the kinetics of plasma glucose, plasma bicarbonate, and the conversion of glucose to CO2 by the hexose monophosphate pathway and all other series and parallel pathways which oxidize glucose carbon to CO2 (EMP-TCA). This formulation separates the distribution kinetics of glucose and bicarbonate from the kinetics of glucose oxidation to CO2. It allows the calculation of a minimal fraction (ϕt) of glucose irreversibly oxidized to CO2 which is based entirely on the duration of the experimental data. This calculation is independent of the extrapolative implications of the model beyond the experimental interval and of the particular model chosen to fit the data. All modeling and data fitting were performed on a digital computer with the SAAM program.

Based on a 300 min experiment the analysis suggests that in hypothyroidism there is a decrease in the rate of glucose metabolized irreversibly (ρG). There is also a decrease in the minimal fraction (ϕ300) which is completely oxidized to CO2 by way of the EMP-TCA. ρG and ϕ300 are 0.56 and 0.42 mmole/min respectively as compared to 0.89 and 0.50 mmole/min respectively in normals. However, the fraction of the C-1 of glucose metabolized irreversibly which undergoes oxidation to CO2 by the hexose monophosphate pathway (Ψ) is not different from normal (0.07 and 0.07 respectively). The hyperthyroid studies suggest that ρG and ϕ300 are within the normal range (1.01 and 0.46 mmoles/min respectively as compared to 0.89 and 0.50 mmole/min respectively in normals). However, Ψ is decreased to less than half the normal value (0.03 as compared to 0.07 in normals).

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 627
page 627
icon of scanned page 628
page 628
icon of scanned page 629
page 629
icon of scanned page 630
page 630
icon of scanned page 631
page 631
icon of scanned page 632
page 632
icon of scanned page 633
page 633
icon of scanned page 634
page 634
icon of scanned page 635
page 635
icon of scanned page 636
page 636
icon of scanned page 637
page 637
icon of scanned page 638
page 638
icon of scanned page 639
page 639
icon of scanned page 640
page 640
icon of scanned page 641
page 641
Version history
  • Version 1 (March 1, 1971): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts